Denlinger CS, Engstrom PF: Colorectal cancer survivorship: movement matters. Cancer Prev Res (Phila). 2011, 4 (4): 502-511. 10.1158/1940-6207.CAPR-11-0098.
Article
CAS
Google Scholar
Ransohoff DF: Colon cancer in ulcerative colitis. Gastroenterology. 1988, 94 (4): 1089-1091.
Article
CAS
PubMed
Google Scholar
Ekbom A, Helmick C, Zack M, Adami HO: Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990, 323 (18): 1228-1233. 10.1056/NEJM199011013231802.
Article
CAS
PubMed
Google Scholar
Medema JP, Vermeulen L: Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature. 2011, 474 (7351): 318-326. 10.1038/nature10212.
Article
CAS
PubMed
Google Scholar
Terzic J, Grivennikov S, Karin E, Karin M: Inflammation and colon cancer. Gastroenterology. 2010, 138 (6): 2101-2114. 10.1053/j.gastro.2010.01.058. e2105
Article
CAS
PubMed
Google Scholar
Levy DE, Darnell JE: Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002, 3 (9): 651-662.
Article
CAS
PubMed
Google Scholar
Yu H, Kortylewski M, Pardoll D: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol. 2007, 7 (1): 41-51. 10.1038/nri1995.
Article
CAS
PubMed
Google Scholar
He G, Karin M: NF-kappaB and STAT3 - key players in liver inflammation and cancer. Cell Res. 2011, 21 (1): 159-168. 10.1038/cr.2010.183.
Article
CAS
PubMed
Google Scholar
Lees CW, Barrett JC, Parkes M, Satsangi J: New IBD genetics: common pathways with other diseases. Gut. 2011, 60 (12): 1739-1753. 10.1136/gut.2009.199679.
Article
CAS
PubMed
Google Scholar
Bollrath J, Phesse TJ, von Burstin VA, Putoczki T, Bennecke M, Bateman T, Nebelsiek T, Lundgren-May T, Canli O, Schwitalla S: gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 2009, 15 (2): 91-102. 10.1016/j.ccr.2009.01.002.
Article
CAS
PubMed
Google Scholar
Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L: IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009, 15 (2): 103-113. 10.1016/j.ccr.2009.01.001.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, Lin J: STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. Cancer Res. 2011, 71 (23): 7226-7237. 10.1158/0008-5472.CAN-10-4660.
Article
CAS
PubMed
PubMed Central
Google Scholar
Matsumoto S, Hara T, Mitsuyama K, Yamamoto M, Tsuruta O, Sata M, Scheller J, Rose-John S, Kado S, Takada T: Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model. J Immunol. 2010, 184 (3): 1543-1551. 10.4049/jimmunol.0801217.
Article
CAS
PubMed
Google Scholar
Steinbrecher KA, Horowitz NA, Blevins EA, Barney KA, Shaw MA, Harmel-Laws E, Finkelman FD, Flick MJ, Pinkerton MD, Talmage KE: Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen. Cancer Res. 2010, 70 (7): 2634-2643. 10.1158/0008-5472.CAN-09-3465.
Article
CAS
PubMed
PubMed Central
Google Scholar
Strober W, Fuss IJ: Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011, 140 (6): 1756-1767. 10.1053/j.gastro.2011.02.016.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dong C: TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol. 2008, 8 (5): 337-348. 10.1038/nri2295.
Article
CAS
PubMed
Google Scholar
Reiner SL: Development in motion: helper T cells at work. Cell. 2007, 129 (1): 33-36. 10.1016/j.cell.2007.03.019.
Article
CAS
PubMed
Google Scholar
Abraham C, Medzhitov R: Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011, 140 (6): 1729-1737. 10.1053/j.gastro.2011.02.012.
Article
CAS
PubMed
PubMed Central
Google Scholar
Morrison PJ, Ballantyne SJ, Kullberg MC: Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity. Immunology. 2011, 133 (4): 397-408. 10.1111/j.1365-2567.2011.03454.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F: Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007, 8 (9): 942-949. 10.1038/ni1496.
Article
CAS
PubMed
Google Scholar
Das J, Ren G, Zhang L, Roberts AI, Zhao X, Bothwell AL, Van Kaer L, Shi Y, Das G: Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med. 2009, 206 (11): 2407-2416. 10.1084/jem.20082286.
Article
CAS
PubMed
PubMed Central
Google Scholar
Erreni M, Mantovani A, Allavena P: Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer Microenviron. 2011, 4 (2): 141-154. 10.1007/s12307-010-0052-5.
Article
CAS
PubMed
Google Scholar
Manel N, Unutmaz D, Littman DR: The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol. 2008, 9 (6): 641-649. 10.1038/ni.1610.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu J, Duan Y, Cheng X, Chen X, Xie W, Long H, Lin Z, Zhu B: IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun. 2011, 407 (2): 348-354. 10.1016/j.bbrc.2011.03.021.
Article
CAS
PubMed
Google Scholar
Radosavljevic G, Ljujic B, Jovanovic I, Srzentic Z, Pavlovic S, Zdravkovic N, Milovanovic M, Bankovic D, Knezevic M, Acimovic LJ: Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma. Neoplasma. 2010, 57 (2): 135-144. 10.4149/neo_2010_02_135.
Article
CAS
PubMed
Google Scholar
Yang S, Wang B, Guan C, Wu B, Cai C, Wang M, Zhang B, Liu T, Yang P: Foxp3 + IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer. J Leukoc Biol. 2011, 89 (1): 85-91. 10.1189/jlb.0910506.
Article
CAS
PubMed
Google Scholar
Kryczek I, Wei S, Szeliga W, Vatan L, Zou W: Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood. 2009, 114 (2): 357-359. 10.1182/blood-2008-09-177360.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R: IL-22 increases the innate immunity of tissues. Immunity. 2004, 21 (2): 241-254. 10.1016/j.immuni.2004.07.007.
Article
CAS
PubMed
Google Scholar
Thompson CL, Plummer SJ, Tucker TC, Casey G, Li L: Interleukin-22 genetic polymorphisms and risk of colon cancer. Cancer Causes Control. 2010, 21 (8): 1165-1170. 10.1007/s10552-010-9542-5.
Article
PubMed
Google Scholar
Nagakawa H, Shimozato O, Yu L, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M: Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts. Scand J Immunol. 2004, 60 (5): 449-454. 10.1111/j.0300-9475.2004.01504.x.
Article
CAS
PubMed
Google Scholar
Fukui H, Sekikawa A, Tanaka H, Fujimori Y, Katake Y, Fujii S, Ichikawa K, Tomita S, Imura J, Chiba T: DMBT1 is a novel gene induced by IL-22 in ulcerative colitis. Inflamm Bowel Dis. 2011, 17 (5): 1177-1188. 10.1002/ibd.21473.
Article
PubMed
Google Scholar
Sekikawa A, Fukui H, Suzuki K, Karibe T, Fujii S, Ichikawa K, Tomita S, Imura J, Shiratori K, Chiba T: Involvement of the IL-22/REG Ialpha axis in ulcerative colitis. Lab Invest. 2010, 90 (3): 496-505. 10.1038/labinvest.2009.147.
Article
CAS
PubMed
Google Scholar
Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann C, Behrendt H: Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest. 2009, 119 (12): 3573-3585.
CAS
PubMed
PubMed Central
Google Scholar
Jiang R, Tan Z, Deng L, Chen Y, Xia Y, Gao Y, Wang X, Sun B: Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology. 2011, 54 (3): 900-909. 10.1002/hep.24486.
Article
CAS
PubMed
Google Scholar
Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A: Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology. 2005, 129 (3): 969-984. 10.1053/j.gastro.2005.06.071.
Article
CAS
PubMed
Google Scholar
Wolk K, Witte E, Witte K, Warszawska K, Sabat R: Biology of interleukin-22. Semin Immunopathol. 2010, 32 (1): 17-31. 10.1007/s00281-009-0188-x.
Article
CAS
PubMed
Google Scholar
Zhang N, Pan HF, Ye DQ: Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem. 2011, 353 (1–2): 41-46.
Article
CAS
PubMed
Google Scholar
Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam K, Cerf-Bensussan N, Mandelboim O: Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity. 2008, 29 (6): 958-970. 10.1016/j.immuni.2008.11.001.
Article
CAS
PubMed
Google Scholar
Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A: IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008, 118 (2): 534-544.
CAS
PubMed
PubMed Central
Google Scholar
Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, Lehr HA, Hirth S, Weigmann B, Wirtz S: STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009, 206 (7): 1465-1472. 10.1084/jem.20082683.
Article
CAS
PubMed
PubMed Central
Google Scholar
Demetris AJ, Lunz JG, Specht S, Nozaki I: Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J Gastroenterol. 2006, 12 (22): 3512-3522.
Article
CAS
PubMed
PubMed Central
Google Scholar
Neufert C, Pickert G, Zheng Y, Wittkopf N, Warntjen M, Nikolaev A, Ouyang W, Neurath MF, Becker C: Activation of epithelial STAT3 regulates intestinal homeostasis. Cell Cycle. 2010, 9 (4): 652-655. 10.4161/cc.9.4.10615.
Article
CAS
PubMed
Google Scholar
te Velde AA, de Kort F, Sterrenburg E, Pronk I, ten Kate FJ, Hommes DW, van Deventer SJ: Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm Bowel Dis. 2007, 13 (3): 325-330. 10.1002/ibd.20079.
Article
PubMed
Google Scholar
Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, Hedl M, Zhang W, O'Connor W, Murphy AJ: IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature. 2012, 491 (7423): 259-263. 10.1038/nature11535.
Article
CAS
PubMed
PubMed Central
Google Scholar
Radaeva S, Sun R, Pan HN, Hong F, Gao B: Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology. 2004, 39 (5): 1332-1342. 10.1002/hep.20184.
Article
CAS
PubMed
Google Scholar
Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA: Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity. 2007, 27 (4): 647-659. 10.1016/j.immuni.2007.07.023.
Article
CAS
PubMed
PubMed Central
Google Scholar
Park O, Wang H, Weng H, Feigenbaum L, Li H, Yin S, Ki SH, Yoo SH, Dooley S, Wang FS: In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology. 2011, 54 (1): 252-261. 10.1002/hep.24339.
Article
PubMed
PubMed Central
Google Scholar
Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP, Pestka S: Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem. 2001, 276 (4): 2725-2732. 10.1074/jbc.M007837200.
Article
CAS
PubMed
Google Scholar
Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL: Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem. 2000, 275 (40): 31335-31339.
Article
CAS
PubMed
Google Scholar
Jones BC, Logsdon NJ, Walter MR: Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure. 2008, 16 (9): 1333-1344. 10.1016/j.str.2008.06.005.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brand S: Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut. 2009, 58 (8): 1152-1167. 10.1136/gut.2008.163667.
Article
CAS
PubMed
Google Scholar
Hruz P, Dann SM, Eckmann L: STAT3 and its activators in intestinal defense and mucosal homeostasis. Curr Opin Gastroenterol. 2010, 26 (2): 109-115. 10.1097/MOG.0b013e3283365279.
Article
CAS
PubMed
Google Scholar